The use of psychotropic medication in the management of problem behaviors in the patient with Alzheimer's disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 7912756.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although a variety of potential alternatives to the neuroleptics in the management of agitated behavior in Alzheimer's disease exist, more large, well-controlled studies are needed. At present, neuroleptics remain the standard treatment for this problem. It is also important for the clinician to investigate thoroughly underlying instigators of behavior change in Alzheimer's patients, such as delirium, anxiety, depression, or environmental factors, and target treatment to these disorders.
Medical subject headings
- Alzheimer Disease
- Mental Disorders
- Psychotropic Drugs